Associate Professor
Community Health and Prevention
267.359.6123
amr395@drexel.edu
T/C
Degrees
PhD, Indiana UniversityMPH, Tulane UniversityBA, Communication Studies and Spanish, Loyola Marymount University
Bio
Prior to pursuing graduate training, Dr. Roth worked for nearly 10 years as a public health practitioner.
Her MPH in international health and development is from Tulane University. She received a PhD in health behavior from Indiana University and then went on to complete a postdoctoral fellowship in substance use and infectious diseases at University of California, San Diego.
Dr. Roth’s research is focused on understanding how individual, social, and environmental factors influence health disparities. In particular, she is interested in the intersection of gender and drug use on women’s health and the use of novel interventions to prevent opioid-related overdoses and increase access to health care among people who use drugs.
The goal of Dr. Roth’s work is to co-create sustainable solutions to public health problems by working in partnership with community members and advocates. To this end, Dr. Roth initiated the health equity advancement lab (HEAL) in 2018. Please check out the HEAL website for current projects and opportunities.
Research Interests
- Substance Use
- Reproductive or Sexual Health
- Community Engaged Research
- Infectious Diseases
- eHealth or mHealth
- Health Disparities
- Urban health
- Mixed Methods
- Women's Health
- Social Determinants of health
Publications
Ataiants J, Roth AM, Mazzella S, Lankenau SE. Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting. Int J Drug Policy. 2020;78:102691. doi:10.1016/j.drugpo.2020.102691.
Felsher M, Ziegler E, Smith LR, Sherman SG, Amico KR, Fox R, Madden K, Roth AM. (2020). An Exploration of Pre-Exposure Prophylaxis Initiation among Women who Inject Drugs. Archives of Sexual Behavior. 49(6):2205-2212. doi.org/10.1007/s10508-020-01684-0.
Roth AM, Kral AH, Mitchell A, Mukherjee R, Davidson P, Lankenau SE. Overdose Prevention Site Acceptability Among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA. J Urban Health. 2019; 96(3):341-352. doi: 10.1007/s11524-019-00364-2.
Roth AM, Tran N, Piecara BL, Shinefeld J, Brady KB. Pre-Exposure Prophylaxis (PrEP) Awareness is Low among Heterosexual People of Color who Might Benefit from PrEP in Philadelphia. J Prim Care Community Health. 2019; Jan-Dec; 10: 2150132719847383. doi:10.1177/2150132719847383.
Felsher M, Szep Z, Krakower D, Martinez-Donate AP, Tran NK, Roth AM. “I Don't Need PrEP Right Now”: A Qualitative Exploration of the Barriers to PrEP Care Engagement Through the Application of the Health Belief Model. AIDS Education and Prevention, 2018;30(5): 369-381. doi: 10.1521/aeap.2018.30.5.369.
Roth AM, Tran NK, Chavis M, Van Der Pol B. Examining Unmet Needs: A Cross Sectional Study Exploring Knowledge, Attitudes, and Sexually Transmitted Infection Screening Preferences among Persons Who Inject Drugs in Camden, New Jersey. Sex Transm Infect.2018;94:598-603. doi: 10.1136/sextrans-2017-053498.
Roth AM, Aumaier B, Felsher M, Welles SE, Martinez-Donate AP, Chavis M, Van Der Pol B. An Exploration of Factors Impacting Pre-exposure Prophylaxis Eligibility and Access among Syringe Exchange Users. Sex Trans Dis. 2018;45(4):217-221. doi: 10.1097/OLQ.0000000000000728.
Roth AM, Rossi J, Goldshear JL, Truong Q, Armenta RF, Lankenau SE, Garfein RS, Simmons J. Potential risks of ecological momentary assessment among persons who inject drugs. Sub Use Misuse. 2017; 52(7):840-847. doi: 10.1080/10826084.2016.1264969.
Roth AM, Felsher M, Reed M, Goldshear JL, Truong Q, Garfein S, Simmons J. Potential Benefits of Using Ecological Momentary Assessment to Study High-risk Polydrug Use. The J mHealth. 2017; 3 (46):1-10. doi: 10.21037/mhealth.2017.10.01.
Roth AM, Armenta RF, Wagner KD, Strathdee SA, Goldshear JL, Cuevas-Mota J, Garfein RS. Cold Preparation of Heroin in a Black Tar Market. Sub Use Misuse. 2017;52(9):1202-1206.
Additional publications on PubMed